Powder: -20°C for 3 years | In solvent: -80°C for 1 year
UNC0642是有效选择性赖氨酸甲基转移酶G9a 和GLP 抑制剂, 抑制G9a 的IC50值小于2.5 nM。
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
1 mg | ¥ 278 | 现货 | ||
2 mg | ¥ 392 | 现货 | ||
5 mg | ¥ 616 | 现货 | ||
10 mg | ¥ 955 | 现货 | ||
25 mg | ¥ 1,850 | 现货 | ||
50 mg | ¥ 3,180 | 现货 | ||
100 mg | ¥ 4,690 | 现货 | ||
200 mg | ¥ 6,610 | 现货 | ||
1 mL * 10 mM (in DMSO) | ¥ 747 | 现货 |
产品描述 | UNC0642 is an effective and specific G9a/GLP inhibitor (IC50< 2.5 nM). |
靶点活性 | G9a:<2.5 nM, GLP:<2.5 nM |
体外活性 | UNC0642 (Ki: 3.7±1 nM) is competitive with the peptide substrate and non-competitive with the cofactor SAM. UNC0642 is more than 300-fold selective for G9a and GLP over a broad range of kinases, transporters, GPCRs, and ion channels. UNC0642 exhibits high potency at low cell toxicity, reducing the H3K9me2 mark, and good separation of functional potency in a number of cell lines. |
体内活性 | UNC0642 (5 mg/kg, i.p.) results in a plasma Cmax of 947 ng/mL and an AUC of 1265 h·ng/ml. |
细胞实验 | MDA-MB-231, PC3, and U2OS cells are treated with UNC0642 for 48 h. Cell viability assays are performed by incubating cells with 0.1 mg/mL of resazurin for 3 – 4 h. Resazurin reduction is monitored with 544 nm excitation, measuring fluorescence at 590 nm. |
动物实验 | Mouse: Standard PK studies are performed using male Swiss albino mice. Plasma and brain concentrations are measured at 0.08, 0.25, 0.5, 1, 2, 4, 8, and 24 h following UNC0642 (5 mg/kg, i.p.). The compound concentration at each time point in plasma or brain is the average value from 3 test animals[1]. |
别名 | UNC-0642, UNC 0642 |
分子量 | 546.7 |
分子式 | C29H44F2N6O2 |
CAS No. | 1481677-78-4 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (91.46 mM), Sonification and heating are recommended.
可选溶剂 | 浓度 体积 质量 | 1 mg | 5 mg | 10 mg | 25 mg |
DMSO | 1 mM | 1.8292 mL | 9.1458 mL | 18.2916 mL | 45.7289 mL |
5 mM | 0.3658 mL | 1.8292 mL | 3.6583 mL | 9.1458 mL | |
10 mM | 0.1829 mL | 0.9146 mL | 1.8292 mL | 4.5729 mL | |
20 mM | 0.0915 mL | 0.4573 mL | 0.9146 mL | 2.2864 mL | |
50 mM | 0.0366 mL | 0.1829 mL | 0.3658 mL | 0.9146 mL |
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
UNC0642 1481677-78-4 Chromatin/Epigenetic Histone Methyltransferase inhibit UNC-0642 Inhibitor UNC 0642 inhibitor